Edition:
United States

Accuray Inc (ARAY.O)

ARAY.O on Nasdaq

4.50USD
22 Sep 2017
Change (% chg)

$0.05 (+1.12%)
Prev Close
$4.45
Open
$4.45
Day's High
$4.50
Day's Low
$4.35
Volume
326,711
Avg. Vol
516,077
52-wk High
$6.39
52-wk Low
$3.60

Select another date:

Tue, Aug 22 2017

BRIEF-Accuray reports Q4 loss per share of $0.06

* Accuray reports fourth quarter and fiscal 2017 financial results

BRIEF-Accuray issues $85 mln principal amount of 3.75 pct convertible senior notes

* Accuray Inc says ‍on August 7, issued $85 million aggregate principal amount of its 3.75% convertible senior notes due 2022 - sec filing​ Source text: (http://bit.ly/2umHI40) Further company coverage:

BRIEF-Accuray says receives 510(k) clearance for IDMS data management system upgrade for Tomotherapy system

* Says receives 510(k) clearance for IDMS data management system upgrade for Tomotherapy system Source text for Eikon: Further company coverage:

BRIEF-Accuray enhances capital structure through convertible debt transactions

* Accuray Inc - company has also entered into agreements to privately sell $32 million aggregate principal amount of new notes for cash to certain other investors

BRIEF-Neuro Spinal Hospital in Dubai to buy Accuray Cyberknife and Radixact Systems

* Accuray Inc - ‍deal was entered into backlog during Accuray's fourth fiscal quarter which ended June 30, 2017​

BRIEF-Accuray Inc signs new revolving loan agreement

* Closed a new $52 million senior secured revolving loan facility with Midcap Financial Trust Source text for Eikon: Further company coverage:

BRIEF-Accuray reports prelim data from phase I trial of breast cancer cure treated with Cyberknife System

* Prelim data from phase I trial evaluating adjuvant stereotactic partial breast irradiation in early stage breast cancer patients treated with Cyberknife System

BRIEF-Accuray Q3 loss per share $0.06

* Accuray Inc - gross product orders totaled $83.8 million for 2017 fiscal Q3 compared to $56.4 million for prior fiscal year period

Select another date: